Argan (AGX) Cash & Equivalents (2010 - 2026)

Argan has disclosed Cash & Equivalents across 17 years of filings, most recently posting $364.5 million for Q3 2026.

• In Q3 2026, Cash & Equivalents rose 104.94% year-over-year to $364.5 million; the TTM figure through Jul 2026 stood at $364.5 million (up 104.94% YoY), while the FY2026 annual figure was $339.5 million, up 133.7% from the prior year.
• Cash & Equivalents came in at $364.5 million for Q3 2026 at Argan, up from $355.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $364.5 million in Q3 2026 to a low of $136.1 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $224.9 million, with a median of $195.9 million recorded in 2023.
• Year-over-year, Cash & Equivalents slumped 68.25% in 2022 and jumped 133.7% in 2026.
• Over 5 years, Cash & Equivalents stood at $136.1 million in 2022, then surged by 36.38% to $185.6 million in 2023, then slipped by 5.51% to $175.3 million in 2024, then jumped by 74.68% to $306.3 million in 2025, then gained by 19.0% to $364.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $364.5 million in Q3 2026, $355.8 million in Q2 2026, and $339.5 million in Q1 2026.